EVARISTE TECHNOLOGIES
EVARISTE TECHNOLOGIES
Social Links:
Industry:
Biotechnology
Founded:
2017-01-01
Address:
Oxford, Oxfordshire, United Kingdom
Country:
United Kingdom
Website Url:
http://www.evaristetechnologies.com
Total Employee:
1+
Status:
Active
Total Funding:
1.4 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SSL By Default Apple Mobile Web Clips Icon Content Delivery Network Google Apps For Business GStatic Google Static Content COVID-19 Sectigo SSL Sectigo Domain SSL
Current Employees Featured
Founder
Official Site Inspections
http://www.evaristetechnologies.com Semrush global rank: 6.08 M Semrush visits lastest month: 1.34 K
- Host name: aacb0a264e514dd48.awsglobalaccelerator.com
- IP address: 75.2.70.75
- Location: Seattle United States
- Latitude: 47.54
- Longitude: -122.3032
- Metro Code: 819
- Timezone: America/Los_Angeles
- Postal: 98108
More informations about "Evariste Technologies"
Evariste - Crunchbase Company Profile & Funding
Evariste advances synthetic lethal oncology using its AI-enabled platform, Frobenius. The company uses its platform to identify novel synthetic lethal …See details»
Evariste | AI Synthetic Lethal Drug Discovery
Evariste is an AI-enabled drug discovery company that develops small molecule therapeutics for synthetic lethal oncology indications using advanced mathematical modelling and machine learning.See details»
Evariste Company Profile 2024: Valuation, Funding
Evariste General Information Description. Developer of an AI-enabled platform designed to advance synthetic lethal oncology. The company's platform …See details»
Evariste - Funding, Financials, Valuation & Investors - Crunchbase
Evariste discovers novel synthetic lethal oncology targets and designs small molecule therapeutics using its AI-enabled platform, Frobenius.See details»
Evariste | VentureRadar
Website: https://www.evariste.com/ Develops AI-driven small molecule therapeutics for oncology, utilizing proprietary technology to identify targets and biomarkers ...See details»
Evariste - Contacts, Employees, Board Members, Advisors & Alumni
Evariste discovers novel synthetic lethal oncology targets and designs small molecule therapeutics using its AI-enabled platform, Frobenius.See details»
Evariste - Products, Competitors, Financials, Employees, …
Evariste focuses on drug discovery in the biotechnology domain. Use the CB Insights Platform to explore Evariste's full profile.See details»
Evariste - Overview, News & Similar companies | ZoomInfo.com
Who is Evariste. Evariste Technologies aims to increase productivity in drug discovery using automated molecular design. It integrates bespoke modeling solutions in to its proprietary …See details»
Evariste Technologies - VentureRadar
At Evariste we have developed the novel concept of synthetic lethal gene signatures, small panels of multi-omic biomarkers which reveal untargeted... ... Find out ...See details»
Evariste Technologies | Sifted: AI-Powered Company Profiles
Explore company profiles in an instant with Sifted. Dive deep into our AI-generated startup descriptions and competitor analysis.See details»
Evariste Technologies: Revenue, Competitors, Alternatives
Evariste Technologies aims to increase productivity in drug discovery using automated molecular design. It integrates bespoke modeling solutions into its proprietary software platform to …See details»
Evariste - LinkedIn
Evariste | 884 followers on LinkedIn. Applying AI to drug discovery | Evariste is an AI-enabled drug discovery company developing small molecule inhibitors of next generation synthetic …See details»
Evariste Technologies - Overview, News & Competitors - ZoomInfo
Evariste Technologies. Business Services · United Kingdom · <25 Employees. Evariste Technologies leverages Bayesian statistics and probabilistic modeling, in combination with …See details»
Arctoris and Evariste Technologies form a joint venture to identify ...
Arctoris and Evariste Technologies announce a joint venture to develop novel small molecule kinase inhibitors for non-small cell lung cancer (NSCLC). The partnership brings together two …See details»
Evariste Technologies | Insights
Already A Biomedtracker Subscriber? You have access to the full company record through your subscription.See details»
Partnership aims to use AI to Identify novel cMET inhibitors for …
Arctoris, a tech-enabled biopharma company, and Evariste Technologies, an AI-drug discovery company, have announced a joint venture to identify novel small molecule kinase inhibitors for …See details»
Oppilotech and Evariste Technologies Announce Partnership to …
Mar 16, 2022 About Evariste Technologies Evariste Technologies leverages Bayesian statistics and probabilistic modeling, in combination with expertise in medicinal chemistry and drug …See details»
- Navigating Biology, Discovering Drugs
London, UK, 16th March 2022 – Oppilotech Ltd, a biotech specialising in systems biology and machine learning platforms to build unique predictive computational models of cells, …See details»
Development of a Covid antiviral - Evariste
Jan 25, 2021 The top compounds selected by Frobenius when passed these criteria are below (left to right) The top two molecules (244 and 448) are the most potent molecules in the …See details»